BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02631876-completion@plaintrial.com
DTSTAMP:20261028T012003Z
DTSTART;VALUE=DATE:202001
SUMMARY:A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of C
 hemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epi
 thelial Ovarian Cancer (EOC)\, Primary Peritoneal or Fallopian Tube Cancer
  — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT02631876
URL:https://plaintrial.com/trial/NCT02631876
END:VEVENT
END:VCALENDAR